Market Overview

Stada Posts Higher 9-Month Profit

Related STDAF
Stada Arzneimittel Q2 Net Profit Up 9%

Stada Arzeneimittel AG (OTC: STDAF) reported a rise in its profit in the first nine months of the year.

Stada's net profit for the period came in at EUR68.4 million ($86.9 million), versus a year-ago loss of EUR6.5 million.

Its sales gained 6% to EUR1.33 billion.

Posted-In: profitEarnings News


Related Articles (STDAF)

View Comments and Join the Discussion!

Partner Center